First Annual U.Va. Venture Summit

First Annual U.Va. Venture Summit

U.Va. Technology Thought Leaders

• Andrew GrimshawTopic…….
• Steve RichTopic……..
• Joe CampbellTopic………
• Brent GunnoeTopic……….

Venture Panel Discussion

“How is the Venture Capitalist evolving to adapt to the global market?”

• Jim Blair Domain Associates: Partner
• Christopher Brightman UVIMCO: Chief Executive Officer

Ed Glassmeyer Oak Investment Partners: Managing Partner

Ashton Newhall Montagu Newhall Associates: General Partner

• Chuck Newhall NEA: General Partner

Agenda

8:30 – 8:40Welcome by Tom Skalak, Vice President for Research

8:45 – 9:05Andrew Grimshaw

9:10 – 9:30Steve Rich

9:35 – 10:05Joe Campbell

10:05 – 10:15Break

10:15 – 10:35Brent Gunnoe

10:40 – 11:25Venture Panel Discussion

11:25 – 11:30 Closing Remarks

University of Virginia Thought-Leaders Biosketches

Joe Campbell Ph.D., Electrical and Computer Engineering

Joe Campbell, the Lucien Carr III professor in the Charles L. Brown Department of Electrical and Computer Engineering (ECE), received the 2009 John Tyndall Award from the IEEE Lasers and Electro-Optics Society and the Optical Society of America. It is the highest award given by the fiber optics industry.

Campbell is a renowned innovator in electrical engineering and nanotechnology and widely credited with having developed the modern-day detectors of laser light used in fiber optics systems in telephone and other telecommunication systems. His current research focus involves photodetectors, small semi-conductor chips that convert light into current or voltage pulses.

Campbell holds degrees in physics from the University of Texas at Austin and the University of Illinois at Urbana-Champaign. Before joining the U.Va. faculty, he served on the faculty of the University of Texas at Austin as professor of electrical and computer engineering and Cockrell Family Regents Chair in Engineering. In 2002, Campbell was named to the National Academy of Engineering, considered one of the highest honors in the engineering professions.

Stephen Rich M.D., Director-Center for Public Health Geonomics

Stephen S. Rich. M.D., one of the worlds' leading epidemiologist and geneticists, directs the new Center for Public Health Genomics. With his leadership, the center works to translate findings from the Human Genome Project into usable science and treatments to benefit patients.

Steve is known internationally for his work in molecular epidemiology, focusing on the genetic basis of diabetes. He is currently the principal investigator and chairman of the Steering Committee for the Type I Diabetes Genetics Consortium and is the chairman of the Steering Committee and co-principal investigator for the Insulin Resistance Atherosclerosis Family Study

He also has collaborated on several projects studying the genetic basis of a wide array of conditions, including diabetic kidney and heart disease, susceptibility to middle ear infections, asthma and stroke.

Steve received his undergraduate degree from North CarolinaStateUniversity and his doctorate in quantitative genetics from PurdueUniversity. He then joined the faculty of the University of Minnesota in the Department of Laboratory Medicine. He later joined the faculty of Wake Forest University School of Medicine, where he was director of the Center for Public Health Genomics.

He has written more than 500 publications including peer-reviewed journal articles, editorial commentary, reviews, book chapters and books. He currently serves as an associate editor for Genetic Epidemiology and Diabetes, as well as serving on the editorial board of Current Diabetes Reviews.

Andrew Grimshaw, Ph.D., Computer Science

Grimshaw anticipated that gigabit networks make possible the realization of

very large nationwide virtual computers comprised of a variety of geographically

distributed high-performance machines and workstations. To realize the potential

ofthe physical infrastructure, software must be developed that is easy to use,

supports large degrees of parallelism in applications code, and manages the

complexity of the underlying physical system for the user. Grimshaw's early

research projects include Mentat and ELFS.

Mentat was an early object-oriented parallel processing system designed to simplify the task of writing parallel programs. ELFS (Extensible File Systems) addresses the I/O crisis brought on by parallel computers. These projects laid the foundation for the creation of Legion, a collaborative project to realize the potential of the NII by constructing a very large virtual computer that spans the globe. Legion addresses issues such as parallelism, fault-tolerance, security, autonomy, heterogeneity, resource management, and access transparency in a multi-language environment. The Legion project helped set the standards for current Grid Computing research, and has also formed the technological basis of Avaki Corporation (now merged with Sybase).

Andrew Grimshaw received his Ph.D. from the University of Illinois at Urbana-Champaign in 1988. He then joined the University of Virginia as an Assistant Professor of Computer Science, and became Associate Professor in 1994 and Professor in 1999.

He is the chief designer and architect of Mentat and Legion. In 1999 he co-founded Avaki Corporation, and served as its Chairman and Chief Technical Officer, until 2005 when Avaki was acquired by Sybase. In 2003 he won the Frost and Sullivan Technology Innovation Award.

Andrew is a member of the Global Grid Forum (GGR) Steering Committee and the Architecture Area Director in the GGF. He has served on the National Partnership for Advanced Computational Infrastructure (NPACI) Executive Committee, the DoD MSRC Programming Environments and Training (PET) Executive Committee, the CESDIS Science Council, the NRC Review Panel for Information Technology, and the Board on Assessment of NIST Programs. He is the author or co-author of over 50 publications and book chapters.

Brent Gunnoe, Ph.D., Department of Chemistry

Venture Panel Biosketches

Jim Blair, Partner: Domain Associates

Mr. Blair has been a Partner of Domain since its founding in 1985. Present board memberships include Cadence Pharmaceuticals, Cell Biosciences, CoDa Therapeutics, Five Prime Therapeutics, GenVault, Helixis, Meritage Pharma, Microchip Biotechnologies, NeuroPace, and Zogenix. Mr. Blair has over 35 years experience with venture and emerging growth companies. In the course of this experience, he has been involved in the creation and successful development at the Board level of over 40 life sciences ventures, including Amgen, Aurora Biosciences, Amylin Pharmaceuticals, Applied Biosystems, Dura Pharmaceuticals, GeneOhm Sciences, Molecular Dynamics, Nuvasive, Pharmion and Volcano. A former managing director of Rothschild Inc., Mr. Blair was directly involved at a senior level with Rothschild/New Court venture capital activities from 1978 to 1985.

From 1969 to 1978, he was associated with F.S. Smithers and Co. and White, Weld and Co., two investment banking firms actively involved with new ventures and emerging growth companies. From 1961 to 1969, Mr. Blair was an engineering manager with RCA Corporation, during which time he received a David Sarnoff Fellowship. He currently serves on the Board of Directors of the Prostate Cancer Foundation, and he is on the Advisory Boards of the Department of Molecular Biology at Princeton University, the Department of Biomedical Engineering at the University of Pennsylvania, and the Board of Counsilors of the USC Stevens Institute for Innovation.

Christopher Brightman, CFAChief Executive Officer: UVIMCO

Chris has executive management responsibility and acts as Chief Investment Officer. He serves as Chairman of the Board for The Investment Fund for Foundations Advisory Services (TIFF) and as an Investment Advisory Committee member of the Virginia Retirement System. He joined UVIMCO in December of 2004.

Chris was previously employed as Chief Investment Officer at Strategic Investment Group, Head of Equity Strategy at UBS Asset Management, Senior Fixed Income Portfolio Manager at Brinson Partners, Vice President and Manager of Asset/Liability Management at Maryland National Bank, and Associate National Bank Examiner at the Comptroller of the Currency. Chris holds the Chartered Financial Analyst designation. He received his BS from Virginia Tech and his MBA from Loyola College of Maryland.

Ed Glassmeyer, Managing Partner/Co-Founder: Oak Investment Partners

Edward F. Glassmeyer, Managing Partner, co-founded Oak Investment Partners with Stewart Greenfield in 1978. Ed focuses on growth equity investing in the Enterprise Software and Services area and is actively involved in Oak’s global initiatives in India and South Korea. He is on the

Board of Directors of Collabera, EquaTerra, Geotrace, Major League Gaming, and Xiotech. He partners with Tony Downer on broadband networking companies GTS (Central Europe) and Zayo, and is a Director of interactive media investment for Major League Gaming. Selected earlier investments include: Seagate (Founding Investor), Aavid Thermal Technologies, CBORD (to Roper Industries), Cogent Communications, Fiber Optic Network Solutions (to ADC), Media Metrix (to Jupiter), Paysys (to First Data), Picture Vision (to Kodak), Spring Tide (to Lucent), and Telica (to Lucent). Ed started his career with Citicorp Venture Capital, and later became Managing Partner of The Sprout Group at Donaldson, Lufkin, & Jenrette (DLJ).

Ed graduated from Princeton University, served as an officer in the Marine Corps, and received his MBA with distinction from The Amos Tuck School at Dartmouth College, where he now serves on the Board of Overseers. Ed was a founding Director of the National Venture Capital Association (NVCA), and received their Lifetime Achievement Award in 2005.

Peter Barris, Managing General Partner:New Enterprise Associates

C. Ashton Newhall, General Partner/Co-Founder: Montagu Newhall Associates

Ashton co-founded Montagu Newhall Associates in 2000, and manages the Company's office in Owings Mills, Maryland. Ashton is a third-generation venture capitalist. Before co-founding Montagu Newhall, he was at T. Rowe Price Associates ("T. Rowe Price"), where he was one of the youngest marketers of the firm's investment management services to both institutions and high net worth investors. Specifically, he marketed T. Rowe Price investment management services to the general partners of venture funds and entrepreneurs in both the United States and abroad. Ashton serves on the Board of Elon University's Martha & Spencer Love School of Business ForHealth Technologies, Inc., Domain Associates, the Limited Partners Board for QuestMark Partners, and the Mid-Atlantic Venture Association Selection Committee.

Ashton graduated from Elon College. He also studied via exchange programs at the University of Legon in Accra, Ghana and Curtin University in Perth, Australia.

Chuck Newhall, General Partner/Co-Founder: NEA

Chuck is a Co-Founder and General Partner of NEA. His investment activities focus on healthcare services, healthcare information services and biopharmaceutical companies. His board memberships include Bravo by ElderHealth, CoGenesys, Hospital Partners of America, Pharmos, Sensors for Medicine & Science, Supernus Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals.

In 1986 he founded the Mid-Atlantic Venture Capital Association (MAVA), which now has over 80 venture capital firms. He is Chairman Emeritus of MAVA.

Chuck served in Vietnam commanding an independent platoon including an initial reconnaissance of Hamburger Hill.

His decorations include the Silver Star and Bronze Star V (1st OLC.) Before co-founding NEA, Chuck was Vice President of T.

Rowe Price Associates (Vice President of their New Horizons Fund).

He received his MBA from the Harvard University Graduate School of Business and his BA in English Literature with honors from

the University of Pennsylvania.